Showing results (111-120 of 161) with videos related to
Sort By:
Pageof 17
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2017
A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritisYunxin Wang, Qiang Wu, Zhihang Liu, et al.Microbiological Research|January 3, 2025
Assessing the risk of TB progression: Advances in blood-based biomarker researchZhaodong Li, Yunlong Hu, Fa Zou, et al.Tuberculosis (Edinburgh, Scotland)|March 9, 2026
Transcriptomic signatures predict severe linezolid-induced peripheral neuropathy and reveal pre-treatment immune and antioxidant dysregulationChenyan Shi, Peize Zhang, Junfeng Zhen, et al.Cell Communication and Signaling : CCS|July 10, 2025
NASP implication in the androgen receptor associated with castration resistance in prostate cancerYun Feng, Jin Sun, Xuan Kang, et al.Frontiers in Immunology|June 6, 2022
Mycobacterium tuberculosis-Induced Upregulation of the COX-2/mPGES-1 Pathway in Human Macrophages Is Abrogated by SulfasalazineWenfei Wang, Yuping Ning, Yejun Wang, et al.The New Phytologist|October 25, 2021
Integrated regulation of periclinal cell division by transcriptional module of BZR1-SHR in Arabidopsis rootsYanchen Tian, Na Zhao, Minmin Wang, et al.Cell Cycle (Georgetown, Tex.)|August 6, 2016
Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophagesGuoliang Zhang, Xi Liu, Wenfei Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2023
Mycobacterium tuberculosis-Induced Prostaglandin J2 and 15-Deoxy-Prostaglandin J2 Inhibit Inflammatory Signals in Human M1 Macrophages via a Negative Feedback LoopYuping Ning, Wenfei Wang, Paul M Jordan, et al.Scientific Reports|December 19, 2015
A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infectionRongrong Zou, Guoliang Zhang, Shaoyuan Li, et al.Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Exploration of the active components and pharmacological mechanism of Compound Longmaining for the treatment of myocardial infarctionJia Li, Xiao Wang, Diaodiao Bu, et al.Pageof 17